{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T09:37:22Z","timestamp":1771925842741,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.vaccine.2010.12.083","type":"journal-article","created":{"date-parts":[[2011,1,6]],"date-time":"2011-01-06T09:15:58Z","timestamp":1294305358000},"page":"1595-1604","source":"Crossref","is-referenced-by-count":50,"title":["Antibody responses in adult and neonatal BALB\/c mice to immunization with novel Bordetella pertussis vaccine formulations"],"prefix":"10.1016","volume":"29","author":[{"given":"Aleksandra","family":"Gracia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Polewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.W.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorne A.","family":"Babiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"January (4)","key":"10.1016\/j.vaccine.2010.12.083_bib0005","first-page":"31","article-title":"Pertussis vaccines\u2014WHO position paper","volume":"80","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2010.12.083_bib0010","first-page":"238","article-title":"Control of pertussis in the world","volume":"45","author":"Galazka","year":"1992","journal-title":"World Health Stat Q"},{"issue":"May (5 Suppl.)","key":"10.1016\/j.vaccine.2010.12.083_bib0015","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/01.inf.0000160708.43944.99","article-title":"Epidemiology of pertussis","volume":"24","author":"Tan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2010.12.083_bib0020","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1128\/IAI.70.7.3521-3528.2002","article-title":"Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis","volume":"70","author":"Roduit","year":"2002","journal-title":"Infect Immun"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.12.083_bib0025","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1128\/IAI.59.12.4715-4719.1991","article-title":"Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection","volume":"59","author":"Bromberg","year":"1991","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.083_bib0030","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1086\/315527","article-title":"Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children","volume":"181","author":"Mahon","year":"2000","journal-title":"J Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.12.083_bib0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infect Immun"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.12.083_bib0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1128\/IAI.61.2.399-410.1993","article-title":"Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model","volume":"61","author":"Mills","year":"1993","journal-title":"Infect Immun"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2010.12.083_bib0045","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1128\/IAI.61.8.3190-3198.1993","article-title":"Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity","volume":"61","author":"Redhead","year":"1993","journal-title":"Infect Immun"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.12.083_bib0050","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1002\/eji.200425092","article-title":"Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells","volume":"34","author":"Byrne","year":"2004","journal-title":"Eur J Immunol"},{"issue":"July (Suppl. 1)","key":"10.1016\/j.vaccine.2010.12.083_bib0055","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jcpa.2007.04.004","article-title":"The challenges of vaccine responses in early life: selected examples","volume":"137","author":"Siegrist","year":"2007","journal-title":"J Comp Pathol"},{"issue":"May (25\u201326)","key":"10.1016\/j.vaccine.2010.12.083_bib0060","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1016\/S0264-410X(01)00028-7","article-title":"Neonatal and early life vaccinology","volume":"19","author":"Siegrist","year":"2001","journal-title":"Vaccine"},{"issue":"July (Suppl. 1)","key":"10.1016\/j.vaccine.2010.12.083_bib0065","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jcpa.2007.04.008","article-title":"Immune responsiveness in the neonatal period","volume":"137","author":"Morein","year":"2007","journal-title":"J Comp Pathol"},{"issue":"May\u2013August (3\u20134)","key":"10.1016\/j.vaccine.2010.12.083_bib0070","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/08830180600743057","article-title":"Adjuvant activity of CpG oligodeoxynucleotides","volume":"25","author":"Klinman","year":"2006","journal-title":"Int Rev Immunol"},{"issue":"May\u2013August (3\u20134)","key":"10.1016\/j.vaccine.2010.12.083_bib0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/08830180600785868","article-title":"Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides","volume":"25","author":"Wilson","year":"2006","journal-title":"Int Rev Immunol"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2010.12.083_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2004.02.022","article-title":"Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides","volume":"97","author":"Mutwiri","year":"2004","journal-title":"J Control Release"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.12.083_bib0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0169-409X(03)00039-5","article-title":"Biodegradable polyphosphazenes for drug delivery applications","volume":"55","author":"Lakshmi","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"issue":"May\u2013June (3)","key":"10.1016\/j.vaccine.2010.12.083_bib0090","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1021\/bm049329t","article-title":"Polyphosphazene polyelectrolytes: a link between the formation of noncovalent complexes with antigenic proteins and immunostimulating activity","volume":"6","author":"Andrianov","year":"2005","journal-title":"Biomacromolecules"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.083_bib0095","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1021\/bm050752r","article-title":"Effect of side group chemistry on the properties of biodegradable L-alanine cosubstituted polyphosphazenes","volume":"7","author":"Singh","year":"2006","journal-title":"Biomacromolecules"},{"issue":"January (7)","key":"10.1016\/j.vaccine.2010.12.083_bib0100","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.vaccine.2006.10.011","article-title":"Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1\/Th2 immune responses in mice immunized with influenza virus antigens","volume":"25","author":"Mutwiri","year":"2007","journal-title":"Vaccine"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2010.12.083_bib0105","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/CMR.00056-05","article-title":"Peptide antimicrobial agents","volume":"19","author":"Jenssen","year":"2006","journal-title":"Clin Microbiol Rev"},{"issue":"April (7\u20138)","key":"10.1016\/j.vaccine.2010.12.083_bib0110","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s00018-007-6475-6","article-title":"Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections","volume":"64","author":"Mookherjee","year":"2007","journal-title":"Cell Mol Life Sci"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2010.12.083_bib0115","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.4049\/jimmunol.176.4.2455","article-title":"Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37","volume":"176","author":"Mookherjee","year":"2006","journal-title":"J Immunol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2010.12.083_bib0120","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4049\/jimmunol.172.2.1146","article-title":"The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization","volume":"172","author":"Davidson","year":"2004","journal-title":"J Immunol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.12.083_bib0125","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1189\/jlb.0704380","article-title":"Impact of LL-37 on anti-infective immunity","volume":"77","author":"Bowdish","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.12.083_bib0130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/AAC.49.5.1727-1732.2005","article-title":"Immunomodulatory activities of small host defense peptides","volume":"49","author":"Bowdish","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2010.12.083_bib0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nbt1288","article-title":"An anti-infective peptide that selectively modulates the innate immune response","volume":"25","author":"Scott","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.12.083_bib0140","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2010.12.083_bib0145","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.0901813","article-title":"Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment","volume":"184","author":"Nijnik","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.12.083_bib0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.immunol.22.012703.104603","article-title":"Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense","volume":"22","author":"Yang","year":"2004","journal-title":"Annu Rev Immunol"},{"issue":"October (4929)","key":"10.1016\/j.vaccine.2010.12.083_bib0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.2683073","article-title":"Mutants of pertussis toxin suitable for vaccine development","volume":"246","author":"Pizza","year":"1989","journal-title":"Science"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.083_bib0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/eji.200324032","article-title":"Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities","volume":"34","author":"Vollmer","year":"2004","journal-title":"Eur J Immunol"},{"issue":"July (34)","key":"10.1016\/j.vaccine.2010.12.083_bib0165","doi-asserted-by":"crossref","first-page":"4662","DOI":"10.1016\/j.vaccine.2009.05.094","article-title":"A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity","volume":"27","author":"Kindrachuk","year":"2009","journal-title":"Vaccine"},{"issue":"July (8)","key":"10.1016\/j.vaccine.2010.12.083_bib0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S1286-4579(01)01421-6","article-title":"Immunity to Bordetella pertussis","volume":"3","author":"Mills","year":"2001","journal-title":"Microbes Infect"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.083_bib0175","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med"},{"issue":"December (5)","key":"10.1016\/j.vaccine.2010.12.083_bib0180","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.vaccine.2004.07.014","article-title":"Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response","volume":"23","author":"Siegrist","year":"2004","journal-title":"Vaccine"},{"issue":"March (11)","key":"10.1016\/j.vaccine.2010.12.083_bib0185","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.vaccine.2009.12.069","article-title":"Efficacy of poly[di(sodium carboxylatophenoxy)phosphazene] (PCPP) as mucosal adjuvant to induce protective immunity against respiratory pathogens","volume":"28","author":"Shim","year":"2010","journal-title":"Vaccine"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2010.12.083_bib0190","first-page":"185","article-title":"Protein release from polyphosphazene matrices","volume":"31","author":"Payne","year":"1998","journal-title":"Adv Drug Deliv Rev"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2010.12.083_bib0195","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4049\/jimmunol.0802586","article-title":"Intracellular receptor for human host defense peptide LL-37 in monocytes","volume":"183","author":"Mookherjee","year":"2009","journal-title":"J Immunol"},{"issue":"September (27\u201328)","key":"10.1016\/j.vaccine.2010.12.083_bib0200","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1016\/j.vaccine.2004.03.032","article-title":"Aluminium adjuvants\u2014in retrospect and prospect","volume":"22","author":"Lindblad","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10018566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T09:30:08Z","timestamp":1592213408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10018566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0264410X10018566"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}